期刊文献+

氨溴特罗口服溶液辅助治疗小儿毛细支气管炎临床观察 被引量:8

The clinical observation of Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution on the treatment of infantile bronchitis
下载PDF
导出
摘要 目的观察氨溴特罗口服溶液辅助治疗小儿毛细支气管炎的临床效果。方法将96例毛细支气管炎患儿随机分为观察组和对照组各48例。对照组仅给予常规综合治疗,治疗组在对照组治疗基础上加用氨溴特罗口服溶液治疗。观察患儿临床症状和体征消失时间及住院时间,比较2组临床疗效。结果观察组治愈率和总有效率分别为70.8%、95.8%,高于对照组的52.1%、83.3%,差异均有统计学意义(P<0.05);临床症状和体征消失时间及住院时间短于对照组,差异均有统计学意义(P<0.05)。结论氨溴特罗口服溶液治疗小儿毛细支气管炎安全有效。 Objective To obseve curative effect of Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution in treatmeint of infantile bronchitis.Methods 96 children with infantile bronchitis were randomly divided into observation group and control goup with 48 in each.The control group only received routine treatment,the observation group was treated with Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution on the basis of the control group.Clinical symptoms and signs disappear time and hospital stay were compared between the 2 groups,and clinical curative effect was observed.Results Cure rate and total effective rate in the observation group were 70.8%,95.8%,higher than that in the control group(52.1%,83.3%);the clinical symptoms and signs disappear time and hospitalization time in the observation group were shorter than those in the control group,and the differences were statistically significant(P0.05).Conclusion Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution is safe and effective in treatment to infantile bronchitis.
出处 《临床合理用药杂志》 2012年第11期49-50,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 氨溴特罗口服溶液 毛细支气管炎 小儿 疗效 Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution Infantile bronchitis Effect
  • 相关文献

参考文献4

二级参考文献21

  • 1牛文琪,袁岚,赖剑锋,艾涛,熊蕾,胡文广.秋季腹泻患儿心肌酶检测及心电图观察:附30例报告[J].临床儿科杂志,1995,13(4):242-242. 被引量:17
  • 2中华人民共和国卫生部.小儿肺炎防治方案[J].中华儿科杂志,1987,25:47-47.
  • 3中华儿科杂志,1999,37(1):32-34.
  • 4龙火崑.临床药物手册[M].北京:金盾出版社,1996.591-592.
  • 5Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy [J], Respir Med, 1998,92:6092.
  • 6Tersmoto S, Suzuki M, Ohga E,et al. Effects of ambroxol on spontaneous or stimulated generation of reaotive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary diseases [ J ]. Pharmacology,1999,59 : 135-141.
  • 7Pfeifer S,Zissel G, Kienast K, et al. Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol [ J ].Eur J Med Res, 1997,2:129-132.
  • 8Pairet M, Engelmann P, Yon Nicolai H, et al, Ambroxol improves the broncho-spasmolytic activity of clenbuterol in the guinea pig[J]. J Pharm Pharmacol, 1997,49 : 184-186.
  • 9W Couet, J Girault. Steady-state bioavailability and pharmacokinetics of ambroxol and clenbuterol administered alone and combined in a new oral formulation[J]. Intern J Clin Pharmacol,Therapy Toxicol, Vol. 27 No. 9-1989 (467-472).
  • 10Michel P, Peter E. Ambroxol improves the broncho-spasmolytic activity of clenbuterol in the guinea-pig[ J]. J Pharm Pharmacol,1997,49,184-186.

共引文献216

同被引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部